Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "J01D" (94)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Cefazolin (J01DB04) 12 products
WHO-DDD
DrugBank.ca
IP
Kefzol 1 g
ampoule(s)
3.10
12.55
10 %
Injection solution: Cefazolinum 1 g
Teva Pharma AG
A / SL / SO
FB
G
L
IP
Kefzol 1 g
10 ampoule(s)
31.00
49.75
10 %
Injection solution: Cefazolinum 1 g
Teva Pharma AG
A / SL / SO
FB
G
L
IP
Kefzol 2 g
10 ampoule(s)
62.00
83.10
10 %
Injection solution: Cefazolinum 2 g
Teva Pharma AG
A / SL / SO
FB
G
L
IP
Cefazolin Labatec 2 g
i.v.
10 x 2 g
49.60
70.35
10 %
Dry substance: Cefazolinum 2 g
Labatec Pharma SA
A / SL / SG
FB
G
IP
Cefazolin Labatec 1 g
i.v./i.m.
1 g
2.48
11.95
10 %
poudre pour solution injectable/pour perfusion: Cefazolinum 1 g
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Cefazolin Labatec 1 g
i.v./i.m.
10 x 1 g
24.80
43.40
10 %
poudre pour solution injectable/pour perfusion: Cefazolinum 1 g
Labatec Pharma SA
A / SL / SG
FB
G
IP
Kefzol 2 g
5 ampoule(s)
PR
87.05
k.A.
Injection solution: Cefazolinum 2 g
Teva Pharma AG
A
FB
G
IP
Cefazolin Sandoz 2 g i.v.
Flasche(n)
PR
PR
k.A.
Lyophilisate: Cefazolinum 2 g
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Cefazolin Sandoz 2 g i.v.
10 Flasche(n)
PR
PR
k.A.
Lyophilisate: Cefazolinum 2 g
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Cefazolin Labatec 2 g
i.v.
2 g
PR
PR
k.A.
Dry substance: Cefazolinum 2 g
Labatec Pharma SA
A
FB
G
IP
Cefazolin Sandoz 1 g
i.m./ i.v.
Durchstechflasche(n)
4.20
9.05
k.A.
Dry substance: Cefazolinum 1 g
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Cefazolin Sandoz 1 g
i.m./ i.v.
10 Durchstechflasche(n)
PR
PR
k.A.
Dry substance: Cefazolinum 1 g
Sandoz
Pharmaceuticals AG
A
FB
G
Cefuroxime (J01DC02) 31 products
WHO-DDD
DrugBank.ca
IP
CI
Cefuroxim Sandoz 500mg
14
15.00
32.75
10 %
Coated tablets: Cefuroximum 500 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Cefuroxim Sandoz 250mg
-
T
14
PR
PR
k.A.
Coated tablets: Cefuroximum 250 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Cefuroxim Sandoz 250mg
-
T
10 x 14
PR
PR
k.A.
Coated tablets: Cefuroximum 250 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Cefuroxim Sandoz 500mg
10 x 14
PR
PR
k.A.
Coated tablets: Cefuroximum 500 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Zinacef 750 mg
Durchstechflasche(n)
4.12
13.70
10 %
Dry substance: Cefuroximum 750 mg
Sandoz
Pharmaceuticals AG
A / SL / SO
FB
G
IP
Zinacef 1.5 g
Durchstechflasche(n)
7.05
16.90
10 %
Dry substance: Cefuroximum 1.5 g
Sandoz
Pharmaceuticals AG
A / SL / SO
FB
G
IP
CI
Zinat 250 mg
-
T
14 Tablet(s)
9.42
26.65
10 %
Coated tablets: Cefuroximum 250 mg
Sandoz
Pharmaceuticals AG
A / SL / SO
FB
G
IP
CI
Zinat 500 mg
‐
I
14 Tablet(s)
16.49
34.25
10 %
Coated tablets: Cefuroximum 500 mg
Sandoz
Pharmaceuticals AG
A / SL / SO
FB
G
IP
CI
Cefuroxim axapharm 250 mg
14 Tablet(s)
9.15
26.35
10 %
Coated tablets: Cefuroximum 250 mg
axapharm ag
A / SL / SG
FB
G
IP
CI
Cefuroxim axapharm 500 mg
14 Tablet(s)
15.00
32.75
10 %
Coated tablets: Cefuroximum 500 mg
axapharm ag
A / SL / SG
FB
G
IP
CI
Cefuroxim Spirig HC 250 mg
14 Tablet(s)
9.15
26.35
10 %
Coated tablets: Cefuroximum 250 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Cefuroxim Spirig HC 500 mg
14 Tablet(s)
15.00
32.75
10 %
Coated tablets: Cefuroximum 500 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Cefuroxim-Mepha 250
14 Tablet(s)
9.15
26.35
10 %
Coated tablets: Cefuroximum 250 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Cefuroxim-Mepha 500
14 Tablet(s)
15.00
32.75
10 %
Coated tablets: Cefuroximum 500 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Zinat
70 ml
8.14
25.25
10 %
Granulat zur Herstellung einer Suspension zum Einnehmen: Cefuroximum 125 mg
Sandoz
Pharmaceuticals AG
A / SL
FB
G
IP
Cefuroxim Fresenius i.v. 750 mg
Durchstechflasche(n) à 15 ml
PR
PR
k.A.
Dry substance: Cefuroximum 750 mg
Fresenius Kabi
(Schweiz) AG
A
FB
G
IP
Cefuroxim Fresenius i.v.
1500 mg
Durchstechflasche(n) à 20 ml
PR
PR
k.A.
Dry substance: Cefuroximum 1500 mg
Fresenius Kabi
(Schweiz) AG
A
FB
G
IP
CI
Cefuroxim-Acino 250 mg
14
PR
PR
k.A.
Coated tablets: Cefuroximum 250 mg
Acino Pharma AG
A
FB
G
IP
CI
Cefuroxim-Acino 500 mg
14
PR
PR
k.A.
Coated tablets: Cefuroximum 500 mg
Acino Pharma AG
A
FB
G
IP
Cefuroxim Labatec i.v. 750 mg
750 mg
PR
PR
k.A.
poudre pour solution injectable: Cefuroximum 750 mg
Labatec Pharma SA
A
FB
G
IP
Cefuroxim Labatec i.v. 750 mg
10 x 750 mg
PR
PR
k.A.
poudre pour solution injectable: Cefuroximum 750 mg
Labatec Pharma SA
A
FB
G
IP
Cefuroxim Labatec i.v. 1,5 g
1.5 g
PR
PR
k.A.
poudre pour solution injectable/pour perfusion: Cefuroximum 1500 mg
Labatec Pharma SA
A
FB
G
IP
Cefuroxim Labatec i.v. 1,5 g
1.5 g
PR
PR
k.A.
poudre pour solution injectable/pour perfusion: Cefuroximum 1500 mg
Labatec Pharma SA
A
FB
G
IP
Cefuroxim Labatec i.v. 1,5 g
10 x 1.5 g
PR
PR
k.A.
poudre pour solution injectable/pour perfusion: Cefuroximum 1500 mg
Labatec Pharma SA
A
FB
G
IP
Cefuroxim Labatec i.v. 1,5 g
10 x 1.5 g
PR
PR
k.A.
poudre pour solution injectable/pour perfusion: Cefuroximum 1500 mg
Labatec Pharma SA
A
FB
G
IP
CI
Cefurox Actavis 125 mg
14 Tablet(s)
6.03
15.10
k.A.
Coated tablets: Cefuroximum 125 mg
Actavis Switzerland AG
A
FB
G
IP
CI
Cefurox Actavis 125 mg
14 Tablet(s)
PR
PR
k.A.
Coated tablets: Cefuroximum 125 mg
Actavis Switzerland AG
A
FB
G
IP
CI
Cefurox Actavis 250 mg
14 Tablet(s)
10.99
20.80
k.A.
Coated tablets: Cefuroximum 250 mg
Actavis Switzerland AG
A
FB
G
IP
CI
Cefurox Actavis 250 mg
14 Tablet(s)
PR
PR
k.A.
Coated tablets: Cefuroximum 250 mg
Actavis Switzerland AG
A
FB
G
IP
CI
Cefurox Actavis 500 mg
14 Tablet(s)
17.69
36.70
k.A.
Coated tablets: Cefuroximum 500 mg
Actavis Switzerland AG
A
FB
G
IP
CI
Cefurox Actavis 500 mg
14 Tablet(s)
PR
PR
k.A.
Coated tablets: Cefuroximum 500 mg
Actavis Switzerland AG
A
FB
G
Cefaclor (J01DC04) 4 products
WHO-DDD
DrugBank.ca
IP
CI
Ceclor 250 mg
100 ml
15.42
33.20
10 %
Granulate: Cefaclorum 250 mg
Alfasigma Schweiz AG
A / SL
FB
G
IP
CI
Ceclor Retard 375 mg
20 Tablet(s)
17.27
35.20
10 %
Coated tablets: Cefaclorum 375 mg
Alfasigma Schweiz AG
A / SL
FB
G
IP
CI
Ceclor Retard 500 mg
20 Tablet(s)
20.77
39.00
10 %
Coated tablets: Cefaclorum 500 mg
Alfasigma Schweiz AG
A / SL
FB
G
IP
CI
Ceclor Retard 750 mg
20 Tablet(s)
32.54
51.80
10 %
Coated tablets: Cefaclorum 750 mg
Alfasigma Schweiz AG
●
A / SL
FB
G
Ceftazidime (J01DD02) 3 products
WHO-DDD
DrugBank.ca
IP
Fortam 1 g
Durchstechflasche(n)
9.69
26.95
10 %
Powder for injection- or infusion solution: Ceftazidimum 1 g
Sandoz
Pharmaceuticals AG
A / SL
FB
G
IP
Fortam 2 g
Durchstechflasche(n)
16.73
34.60
10 %
Powder for injection- or infusion solution: Ceftazidimum 2 g
Sandoz
Pharmaceuticals AG
A / SL
FB
G
IP
Fortam 500 mg
Durchstechflasche(n)
5.29
15.00
10 %
Dry substance: Ceftazidimum 500 mg
Sandoz
Pharmaceuticals AG
A / SL
FB
G
Ceftriaxone (J01DD04) 20 products
WHO-DDD
DrugBank.ca
L
IP
Rocephin 1 g i.v.
1 +
11.22
21.10
10 %
Lyophilisate and solvent: Ceftriaxonum 1 g
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
IP
Rocephin 2 g i.v.
Durchstechflasche(n)
23.41
41.05
10 %
Lyophilisate: Ceftriaxonum 2 g
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
IP
Ceftriaxon Labatec 2 g
i.v.
2 g
9.90
27.20
10 %
Dry substance: Ceftriaxonum 2000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 2 g
i.v.
10 x 2 g
84.15
107.95
10 %
Dry substance: Ceftriaxonum 2000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 1 g
i.v./i.m.
1 g
6.15
15.90
10 %
poudre pour solution injectable: Ceftriaxonum 1000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 1 g
i.v./i.m.
10 x 1 g
52.25
73.25
10 %
poudre pour solution injectable: Ceftriaxonum 1000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Rocephin 1 g i.m.
1 +
11.22
28.60
10 %
Lyophilisate and solvent: Lidocaini Hydrochloridum Anhydricum 35mg / 3.5ml
Lyophilisate and solvent: Ceftriaxonum 1 g
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Rocephin 500 mg i.v.
1 +
11.15
28.55
10 %
Lyophilisate and solvent: Ceftriaxonum 500 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
Ceftriaxon Lagap 500 mg
i.v.
PR
PR
k.A.
Polvere per soluzione iniettabile: Ceftriaxonum 500 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 500 mg
i.v.
10
PR
PR
k.A.
Polvere per soluzione iniettabile: Ceftriaxonum 500 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 1000 mg
i.v./i.m.
PR
PR
k.A.
Polvere per soluzione iniettabile: Ceftriaxonum 1000 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 1000 mg
i.v./i.m.
10
PR
PR
k.A.
Polvere per soluzione iniettabile: Ceftriaxonum 1000 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 2000 mg
i.v.
PR
PR
k.A.
Polvere per soluzione per infusione: Ceftriaxonum 2000 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 2000 mg
i.v.
10
PR
PR
k.A.
Polvere per soluzione per infusione: Ceftriaxonum 2000 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Labatec 250 mg
i.m.
10 x 250 mg
PR
PR
k.A.
poudre pour solution injectable: Ceftriaxonum 250 mg
Labatec Pharma SA
A
FB
G
IP
Ceftriaxon Labatec 500 mg
i.v.
10 x 500 mg
PR
PR
k.A.
poudre pour solution injectable: Ceftriaxonum 500 mg
Labatec Pharma SA
A
FB
G
IP
Ceftriaxon OrPha 1 g
1 g
11.50
25.50
k.A.
OrPha Swiss GmbH
A
FB
G
IP
Ceftriaxon OrPha 2 g
2 g
17.00
35.90
k.A.
OrPha Swiss GmbH
A
FB
G
IP
Ceftriaxon OrPha 1 g
5 x 1 g
PR
PR
k.A.
OrPha Swiss GmbH
A
FB
G
IP
Ceftriaxon OrPha 2 g
5 x 2 g
PR
PR
k.A.
OrPha Swiss GmbH
A
FB
G
Cefpodoxime (J01DD13) 4 products
WHO-DDD
DrugBank.ca
IP
CI
Cefpodoxim Sandoz 100
10 Tablet(s)
5.10
14.80
10 %
Coated tablets: Cefpodoximum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Cefpodoxim Sandoz 100
20 Tablet(s)
8.99
26.20
10 %
Coated tablets: Cefpodoximum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Cefpodoxim Sandoz 200
10 Tablet(s)
10.22
27.55
10 %
Coated tablets: Cefpodoximum 200 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Cefpodoxim Sandoz 200
20 Tablet(s)
18.35
36.35
10 %
Coated tablets: Cefpodoximum 200 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
Ceftazidime and Beta-Lactamase Inhibitor (J01DD52) 1 products
WHO-DDD
DrugBank.ca
L
IP
Zavicefta
10
1151.31
1268.55
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: 2 Active Agents
Pfizer AG
A / SL
FB
G
Cefepime (J01DE01) 4 products
WHO-DDD
DrugBank.ca
Cefepime OrPha 1 g
10
PR
PR
k.A.
Dry substance: Cefepimum 1000 mg
OrPha Swiss GmbH
A
FB
G
Cefepime OrPha 2 g
10
PR
PR
k.A.
Dry substance: Cefepimum 2000 mg
OrPha Swiss GmbH
A
FB
G
IP
Cefepime OrPha 1 g
10
77.89
101.15
10 %
Dry substance: Cefepimum 1 g
OrPha Swiss GmbH
A / SL / SG
FB
G
IP
Cefepime OrPha 2 g
10
140.13
168.80
10 %
Dry substance: Cefepimum 2 g
OrPha Swiss GmbH
A / SL / SG
FB
G
Aztreonam (J01DF01) 2 products
WHO-DDD
DrugBank.ca
L
IP
CI
PP
Cayston
88 Durchstechflasche(n)
2674.00
2924.55
10 %
Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler (mit Altera-Vernebler): Aztreonamum 75 mg
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
IP
Azactam 2 g
PR
PR
k.A.
Dry substance: Aztreonamum 2 g
Bristol-Myers Squibb SA
A
FB
G
Meropenem (J01DH02) 6 products
WHO-DDD
DrugBank.ca
L
IP
Meronem i.v. 500 mg
10 Durchstechflasche(n)
131.49
158.20
20 %
Powder for injection- or infusion solution: Meropenemum 500 mg
Pfizer AG
A / SL / SO
FB
G
L
IP
Meronem i.v. 1 g
10 Durchstechflasche(n)
253.55
289.85
20 %
Powder for injection- or infusion solution: Meropenemum 1 g
Pfizer AG
A / SL / SO
FB
G
L
IP
Meropenem Fresenius i.v. 500 mg
10 x 500 mg
111.75
137.95
10 %
Dry substance: Meropenemum 500 mg
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
L
IP
Meropenem Fresenius i.v. 1 g
10 x 1 g
215.52
250.80
10 %
Dry substance: Meropenemum 1000 mg
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
L
IP
Meropenem Labatec i.v. 500 mg
10 x 500 mg
111.69
137.90
10 %
poudre pour injection ou perfusion: Meropenemum 500 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Meropenem Labatec i.v. 1 g
10 x 1 g
215.52
250.80
10 %
poudre pour injection ou perfusion: Meropenemum 1 g
Labatec Pharma SA
A / SL / SG
FB
G
Ertapenem (J01DH03) 1 products
WHO-DDD
DrugBank.ca
SIP
IP
CI
Invanz
48.17
68.80
10 %
Lyophilisate: Ertapenemum 1 g
MSD Merck Sharp &
Dohme AG
A / SL
FB
G
Imipenem and Cilastatin (J01DH51) 2 products
WHO-DDD
DrugBank.ca
IP
Imipenem-Cilastatin-Mepha
i.v.
10
PR
PR
k.A.
Lyophilisate: 2 Active Agents
Mepha Pharma AG
A
FB
G
IP
Imipenem-Cilastatin
Labatec
10 x 500 mg
PR
PR
k.A.
Dry substance: 2 Active Agents
Labatec Pharma SA
A
FB
G
Meropenem and Vaborbactam (J01DH52) 1 products
WHO-DDD
IP
Vaborem 1g/1g
6
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: 2 Active Agents
A. Menarini GmbH
A
FB
G
Ceftobiprole Medocaril (J01DI01) 1 products
WHO-DDD
DrugBank.ca
IP
Zevtera
10 Durchstechflasche(n)
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Ceftobiprolum 500 mg
Advanz Pharma
Specialty Medicine
Switzerland GmbH
A
FB
G
Ceftaroline Fosamil (J01DI02) 1 products
WHO-DDD
DrugBank.ca
IP
Zinforo
10 Durchstechflasche(n)
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Ceftarolinum Fosamilum 600 mg
Pfizer AG
A
FB
G
Ceftolozane and Beta-Lactamase Inhibitor (J01DI54) 1 products
WHO-DDD
DrugBank.ca
IP
PP
Zerbaxa 1.5 g
10
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: 2 Active Agents
MSD Merck Sharp &
Dohme AG
A
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
